If you’ve been diagnosed with hepatitis C, the most important thing to know is that it’s curable. Modern antiviral medications cure more than 95% of cases with just 8 to 12 weeks of oral treatment. But getting to that cure involves several steps: confirming the diagnosis, assessing your liver health, starting treatment, and making a few practical changes to protect yourself and others in the meantime.
Confirm the Diagnosis With Follow-Up Testing
A positive hepatitis C antibody test doesn’t necessarily mean you have an active infection. Antibodies can linger in your blood for years after your body has cleared the virus on its own, which happens in roughly 15 to 25% of people who are initially infected. The next step is a follow-up blood test called an HCV RNA PCR test, which looks for the actual virus in your bloodstream. If that test comes back positive, the infection is active and needs treatment.
In some cases, your provider will also order genotype testing, which identifies the specific strain of hepatitis C you carry. This was more important when different strains required different medications, but today’s standard treatments work across all genotypes with cure rates above 95%. Genotype testing is still recommended if you have cirrhosis or if a previous round of treatment didn’t work, since those situations can affect which regimen is best.
Get Your Liver Assessed
Before starting treatment, your provider needs to know how much damage the virus has already done to your liver. Hepatitis C causes slow, progressive scarring called fibrosis, and in advanced cases, cirrhosis. The degree of scarring shapes your treatment plan and determines what kind of monitoring you’ll need afterward.
The most common way to check for liver scarring is a painless imaging test called a FibroScan, which measures liver stiffness using sound waves. It has about 87% sensitivity and 91% specificity for detecting cirrhosis. Your provider may also use blood-based scoring tools called APRI and FIB-4, which calculate a fibrosis estimate from routine lab values like liver enzymes, platelet count, and age. These noninvasive methods have largely replaced liver biopsy, which, while still considered the gold standard, carries risks of complications and is less commonly performed today.
FibroScan does have limitations. It’s less accurate in people with a BMI over 30, those with fluid buildup in the abdomen, or during an acute flare when liver enzymes are very elevated. In those situations, your provider may rely more heavily on blood-based scores or, rarely, recommend a biopsy.
How Treatment Works
Hepatitis C treatment today is remarkably straightforward. You take one or two pills daily for 8 to 12 weeks. These are called direct-acting antivirals (DAAs), and they attack the virus at multiple stages of its life cycle. The medications are well tolerated, with side effects that are generally mild compared to the older interferon-based treatments that were standard before 2014.
Cure rates with current regimens are extraordinary. A pooled real-world analysis across multiple virus strains found an overall cure rate of 98.9%, including 97.9% in patients who already had compensated cirrhosis. For most people without cirrhosis, an 8-week course is sufficient. Those with cirrhosis or prior treatment failure typically take a 12-week course. You’re considered cured if the virus is undetectable in your blood 12 weeks after finishing treatment, a milestone called sustained virologic response (SVR).
Being cured means the virus is gone from your body permanently. Your liver can begin to heal, and if scarring hasn’t progressed to cirrhosis, significant reversal of fibrosis is possible over time. However, a cure doesn’t make you immune. You can be reinfected if you’re exposed to the virus again.
Paying for Treatment
The sticker price of hepatitis C medication can be daunting, but most people don’t pay full price. Several pathways can reduce or eliminate your out-of-pocket cost. If you have private insurance, most plans now cover DAA treatment, though you may need prior authorization. Medicaid covers treatment in all 50 states, and a federal rebate program offsets drug costs for Medicaid beneficiaries. Some states, like Louisiana, have negotiated flat-rate contracts with drug manufacturers for unlimited treatment access.
If you’re uninsured or underinsured, the 340B federal program allows qualifying health centers and hospitals to dispense medications at significantly reduced prices. Drug manufacturers also run patient assistance programs that provide medication at no cost to eligible applicants. The Department of Veterans Affairs has cured over 100,000 veterans through its own coordinated screening and treatment program. Your prescribing provider or a patient navigator at your clinic can help you identify which option fits your situation.
Protect Others From Transmission
Hepatitis C spreads through blood-to-blood contact. It is not spread through casual contact, sharing food, hugging, or kissing. Household transmission is rare, but a few simple precautions eliminate the risk almost entirely. Don’t share razors, toothbrushes, nail clippers, or any personal item that could have trace amounts of blood on it. Cover any open wounds with bandages, and clean up blood spills with a bleach-based disinfectant.
Sexual transmission is uncommon in monogamous heterosexual relationships but occurs at higher rates among men who have sex with men, particularly when there’s a risk of blood exposure. Using barrier protection reduces this risk. If you inject drugs, never share needles, syringes, or preparation equipment.
Get Vaccinated Against Hepatitis A and B
There’s no vaccine for hepatitis C, but getting vaccinated against hepatitis A and B is strongly recommended if you haven’t already. These are different viruses that also attack the liver, and catching either one on top of an existing hepatitis C infection can cause severe complications, including fulminant hepatitis, a life-threatening form of acute liver failure.
Both the WHO and the American Association for the Study of Liver Diseases recommend hepatitis A and B vaccines for people with chronic hepatitis C. No special dosing schedule is needed for the hepatitis A vaccine. For hepatitis B, it’s best to get vaccinated early in the course of your hepatitis C infection, because the vaccine may produce a weaker immune response in people who have already developed cirrhosis. Your provider can check your antibody levels with a simple blood test to see if you’re already protected.
Alcohol and Your Liver
If you drink alcohol, reducing or stopping is one of the most impactful things you can do for your liver. Heavy drinking dramatically accelerates the progression from chronic hepatitis C to cirrhosis and liver cancer. In a study of over 2,200 people with hepatitis C, those who drank more than about four drinks per day showed significantly more advanced liver scarring. Among patients who developed cirrhosis, the disease appeared considerably sooner in heavy drinkers.
Even moderate drinking may not be safe. While the evidence is less definitive, several studies suggest that moderate-to-heavy alcohol consumption increases the risk of fibrosis progression in people with hepatitis C. Other factors that accelerate liver damage include obesity, fatty liver disease, being male, and being infected after age 40. Of these, alcohol is the one you have the most control over. Abstinence is the safest approach, especially if you already have some degree of fibrosis.
Over-the-Counter Pain Relievers
Managing everyday aches and pains requires a bit more thought when you have hepatitis C. Acetaminophen (Tylenol) is the safest choice when used at standard doses. For people without cirrhosis, up to 4 grams per day is considered safe. If you do have cirrhosis, keep your daily dose under 2 grams.
Common anti-inflammatory painkillers like ibuprofen and naproxen should be avoided, especially if you have cirrhosis. These medications carry risks of kidney injury and gastrointestinal bleeding that are amplified in people with liver disease. Topical versions of anti-inflammatory gels are generally considered safer since they bypass the liver, but check with your provider before using them regularly.
What to Expect After You’re Cured
Once you achieve SVR, meaning the virus is undetectable 12 weeks after treatment, your risk of liver-related complications drops substantially. For people without cirrhosis at the time of treatment, ongoing monitoring is typically minimal. Your liver enzymes should normalize, and existing fibrosis can gradually improve.
If you had cirrhosis before or during treatment, you’ll need continued monitoring even after the virus is cleared. The risk of liver cancer, while reduced, doesn’t disappear entirely, so most guidelines recommend ongoing imaging surveillance every six months. Your provider will outline a follow-up schedule based on the degree of scarring found before treatment. Curing the virus is the single biggest step you can take, but for those with advanced disease, it’s the beginning of long-term liver health management rather than the end of it.